NCT00334568View on ClinicalTrials.gov

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

PHASE2TerminatedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Alzheimer's Disease

Interventions

DRUG

Rosiglitazone XR (extended release) oral tablets

Rosi XR tablets

DRUG

Placebo

Placebo

Trial Locations (1)

CB2 2EF

GSK Investigational Site, Cambridge

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY